High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US9828622B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9828622-B2 |
| Application number | US-99099709-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 5, 2009 |
| Priority date | May 5, 2008 |
| Publication date | Nov 28, 2017 |
| Grant date | Nov 28, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides photosensitizer compounds for use in detecting beta-lactamase activity. Methods and kits that utilize the photosensitizer compounds of the invention for the detection of, quantitation of, and classification or typing of microbial beta-lactamases.
Opening claim text (preview).
What is claimed is: 1. A method of measuring susceptibility of beta-lactamase secreting bacteria in a sample to a beta-lactam antibiotic, wherein, the method comprises: (a) contacting the sample with: (i) a composition comprising a cephalosporin linker compound linked with two benzophenothiazinium chloride (EtNBS) fluorophores (standard); and (ii) a composition comprising the beta-lactam antibiotic and the cephalosporin linker compound linked with two EtNBS fluorophores (test sample), wherein, the EtNBS fluorophores are (Z)-5-((9-(diethylamino)-5H-benzo[a]phenothiazin-5-ylidene)amino)pentanoic acid (EtNBS-COOH) derived fluorophores; (b) light-activating the standard and the test compositions to produce a fluorescence signal; (c) quantifying the fluorescence signal with a detector to obtain result; (d) comparing the test result to the standard result; and (e) if the amount of the measured fluorescence in the test sample is less than the amount of measured fluorescence in the standard sample, then the β-lactamase secreting bacteria is determined to be susceptible to the β-lactam antibiotic. 2. The method of claim 1 , wherein, the EtNBS fluorophores are conjugated to the cephalosporin linker via amide bond. 3. The method of claim 2 , wherein at least one fluorophore is bound at the 3′ position of the cephalosporin linker. 4. The method of claim 3 , wherein, the cephalosporin linker compound linked with two EtNBS fluorophores is a compound of the structure:
acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6) · CPC title
involving hydrolase · CPC title
Antibacterial agents · CPC title
with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title
Bacteria · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.